Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

Experts in dermatology presented ways in which biologic therapies can be given and the duration of treatment when used in pediatric patients with skin conditions. Treating pediatric patients with ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

Please provide your email address to receive an email when new articles are posted on . Less than 15% of PCPs reported managing patients with uncontrolled asthma at least once a week. More PCPs ...

CMO, discussed a presentation from Maui Derm 2026 in which he spoke about therapies in the pipeline for psoriasis.

Antibiotic exposure in psoriasis patients is linked to increased biologic therapy discontinuation, with risk rising with multiple courses, suggesting gut microbiota alterations may play a role. The ...

Rectal adenocarcinoma, eosinophilic esophagitis, inflammatory bowel disease, diverticular perforation, and irritable bowel syndrome are among the gastrointestinal adverse events associated with the ...

Early initiation of biologic therapy in patients with Crohn’s disease (CD) is associated with higher rates of transmural healing and leads to improved long-term outcomes. In CD, early initiation of ...

Worries have persisted that cancer survivors in remission might face increased recurrence risk when treated with biologic drugs for autoimmune disease. This Danish study of rheumatoid arthritis ...

Biologic Therapies has announced it has received FDA clearance for its new bone marrow aspiration catheter, according to a news release. The Bio-MAC bone marrow aspiration catheter is designed to ...